As part of the implementation of the ‘one substance, one assessment’ approach, provisions have been introduced in a proposal for a Regulation amending Union pharmaceutical legislation in order to give the European Medicines Agency a mandate to develop and cooperate on the development of assessment methodologies, standard formats and controlled vocabularies and to exchange data and information on chemicals, as well as to provide for new procedures to ensure consistency between scientific opinions.
Recital 4, Regulation (EU) 2025/2457
In forcesince 26 Nov 2025